GGrantIndex
← Leaderboards

Farhad R. Danesh

Northwestern University

$12,807,880
Attributed
$12,807,880
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $816.7K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,807,880 · 5

By mechanism

R01$12,795,624 · 4
P41$12,256 · 1

Top collaborators

No co-investigators on record.

Most similar at Northwestern University

Same institution · by research overlap

Others in their field

Top investigators on “Kidney

Research focus

KidneyDiabetic NephropathyIn VivoMediatingDiabeticPathogenesisGlucoseMolecularProteinsBaseMitochondriaPodocyteBiologicalSignal TransductionDiabetes MellitusExperimental ModelsTherapeutic TargetPlayGeneticIn VitroExpectationPreventFunctional DisorderInsight

Grant awards (37)

Regulation of Mitochondrial Respiration in Diabetic Kidney Disease$579,097
R01 · FY2025 · DK · contact PI
MicroRNA In Diabetic Nephropathy$437,747
R01 · FY2024 · DK · contact PI
Role of Rho Kinase in Diabetic Nephropathy$342,144
R01 · FY2024 · DK · contact PI
MicroRNA In Diabetic Nephropathy$458,839
R01 · FY2023 · DK · contact PI
Role of Rho Kinase in Diabetic Nephropathy$356,400
R01 · FY2023 · DK · contact PI
MicroRNA In Diabetic Nephropathy$455,988
R01 · FY2022 · DK · contact PI
Role of Rho Kinase in Diabetic Nephropathy$356,400
R01 · FY2022 · DK · contact PI
MicroRNA In Diabetic Nephropathy$460,263
R01 · FY2021 · DK · contact PI
Role of Rho Kinase in Diabetic Nephropathy$356,400
R01 · FY2021 · DK · contact PI
MicroRNA In Diabetic Nephropathy$360,000
R01 · FY2020 · DK · contact PI
Role of Rho Kinase in Diabetic Nephropathy$356,400
R01 · FY2020 · DK · contact PI
MicroRNA In Diabetic Nephropathy$360,000
R01 · FY2019 · DK · contact PI
MicroRNA In Diabetic Nephropathy$360,000
R01 · FY2018 · DK · contact PI
Role of Rho Kinase in Diabetic Nephropathy$348,000
R01 · FY2018 · DK · contact PI
MicroRNA In Diabetic Nephropathy$360,000
R01 · FY2017 · DK · contact PI
Role of Rho Kinase in Diabetic Nephropathy$348,000
R01 · FY2017 · DK · contact PI
MicroRNA In Diabetic Nephropathy$360,000
R01 · FY2016 · DK · contact PI
Role of Rho Kinase in Diabetic Nephropathy$348,000
R01 · FY2016 · DK · contact PI
MicroRNA In Diabetic Nephropathy$348,000
R01 · FY2015 · DK · contact PI
Role of Rho Kinase in Diabetic Nephropathy$348,000
R01 · FY2015 · DK · contact PI
MicroRNA In Diabetic Nephropathy$348,000
R01 · FY2014 · DK · contact PI
Role of Rho Kinase in Diabetic Nephropathy$348,000
R01 · FY2014 · DK · contact PI
MicroRNA In Diabetic Nephropathy$335,821
R01 · FY2013 · DK · contact PI
Role of Rho Kinases in Diabetic Nephropathy$239,130
R01 · FY2013 · DK · contact PI
Role of Rho Kinases in Diabetic Nephropathy$88,000
R01 · FY2013 · DK · contact PI
MicroRNA In Diabetic Nephropathy$340,388
R01 · FY2012 · DK · contact PI
Role of Rho Kinases in Diabetic Nephropathy$325,758
R01 · FY2012 · DK · contact PI
MicroRNA In Diabetic Nephropathy$340,388
R01 · FY2011 · DK · contact PI
Role of Rho Kinases in Diabetic Nephropathy$325,801
R01 · FY2011 · DK · contact PI
ROCK1 IN DIABETIC NEPHROPATHY$12,256
P41 · FY2011 · RR · contact PI
Role of Rho Kinases in Diabetic Nephropathy$363,182
R01 · FY2010 · DK · contact PI
Role of Rho Kinases in Diabetic Nephropathy$379,811
R01 · FY2009 · DK · contact PI
Statins and VEGF-induced cytoskeletal remodeling$335,193
R01 · FY2009 · DK · contact PI
Statins and VEGF-induced cytoskeletal remodeling$335,193
R01 · FY2008 · DK · contact PI
Statins and VEGF-induced cytoskeletal remodeling$322,851
R01 · FY2007 · DK · contact PI
Statins and VEGF-induced cytoskeletal remodeling$332,494
R01 · FY2006 · DK · contact PI
Statins and VEGF-induced cytoskeletal remodeling$335,936
R01 · FY2005 · DK